Ginkgo Bioworks Holdings Stock (NYSE: DNA) stock price, news, charts, stock research, profile.
Open | $0.505 |
Close | $0.516 |
Volume / Avg. | 26.486M / 40.406M |
Day Range | 0.492 - 0.523 |
52 Wk Range | 0.492 - 2.545 |
Market Cap | $1.150B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NYSE |
RSI | 32 |
Short Interest | 22.27% |
Days to Cover | 4.26 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Ginkgo Bioworks Holdings (NYSE: DNA) through any online brokerage.
Other companies in Ginkgo Bioworks Holdings’s space includes: DuPont de Nemours (NYSE:DD), PPG Indus (NYSE:PPG), Intl Flavors & Fragrances (NYSE:IFF), Sensient Technologies (NYSE:SXT) and RPM Intl (NYSE:RPM).
The latest price target for Ginkgo Bioworks Holdings (NYSE: DNA) was reported by BTIG on Wednesday, May 15, 2024. The analyst firm set a price target for 0.00 expecting DNA to fall to within 12 months (a possible -100.00% downside). 9 analyst firms have reported ratings in the last year.
The stock price for Ginkgo Bioworks Holdings (NYSE: DNA) is $0.5199 last updated June 11, 2024 at 7:45 PM EDT.
There are no upcoming dividends for Ginkgo Bioworks Holdings.
Ginkgo Bioworks Holdings’s Q2 earnings are confirmed for Wednesday, August 7, 2024.
There is no upcoming split for Ginkgo Bioworks Holdings.
Ginkgo Bioworks Holdings is in the Materials sector and Chemicals industry. They are listed on the NYSE.